GleanMark

SRT THERAPEUTICS Trademark

SRT THERAPEUTICS is a USPTO trademark filed by SRT Therapeutics, Inc.. Status: Pending.

Trademark Facts

MarkSRT THERAPEUTICS
Serial Number99645250
StatusPending
Filing Date2026-02-10
Mark TypeCombined
Nice Classes005 (Pharmaceuticals), 009 (Electronics & Software), 042 (Software & IT), 044 (Medical Services)
OwnerSRT Therapeutics, Inc.
Attorney of RecordAaron D. Hendelman
Prosecution Events2
Latest EventMAFR on 2026-02-10

Goods & Services

Class 005: Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; pharmaceutical preparations for the treatment of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use; pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine; Class 009: Downloadable software for interacting and managing a database; Downloadable software featuring a database of clinical and genomic data for use in scientific research, pharmaceutical development, diagnostics, and medicine; Class 042: Medical laboratory services, namely, laboratory testing, medical diagnostic testing, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection; laboratory testing services to provide specific precision medicine test results; clinical and medical research in the fields of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine; Class 044: Disease management services; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; providing health information in the fields of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing a website featuring information about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, and Inflammatory Bowel Disease; providing a website featuring information about services for the diagnosis, prevention, and treatment of oncological, cardiovascular, metabolic, autoimmune, inflammatory, infectious, neurological, psychiatric, respiratory, dermatological, musculoskeletal, hematological, ophthalmological, and endocrine diseases and disorders; providing health information in the fields of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine; providing personalized healthcare and medical information in the nature of gene therapy, cell therapy, regenerative medicine, personalized medicine, precision medicine

Related